Source link : https://www.newshealth.biz/health-news/pembrolizumab-approved-with-chemotherapy-for-mpm/
Pembrolizumab (Keytruda, Merck) has picked up another indication — this time for the first-line treatment of unresectable advanced or metastatic malignant pleural mesothelioma (MPM) in combination with pemetrexed and platinum chemotherapy. With the US Food and Drug Administration’s September 17 approval, Merck’s blockbuster programmed cell death protein 1 (PD-1) inhibitor now has indications across 21 […]
Author : News Health
Publish date : 2024-09-19 10:16:16
Copyright for syndicated content belongs to the linked Source.
inHealth